Strata Critical Medical (SRTA) Depreciation and Depletion (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Depreciation and Depletion data on file, last reported at $1.6 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $1.6 million, up 92.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (up 87.34% YoY), and the FY2025 annual result was $4.3 million, up 114.8% from the prior year.
• Depreciation and Depletion rose to $1.6 million in Q1 2026 per SRTA's latest filing, from $1.5 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $1.6 million in Q1 2026 and troughed at $148000.0 in Q1 2022.
• A 5-year average of $737769.2 and a median of $663000.0 in 2024 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2024 and 2025: Depreciation and Depletion surged 184.25% in 2024, then jumped 55.43% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $148000.0 in 2022, then surged by 84.46% to $273000.0 in 2023, then surged by 184.25% to $776000.0 in 2024, then surged by 97.42% to $1.5 million in 2025, then grew by 2.74% to $1.6 million in 2026.
• Business Quant data shows SRTA's Depreciation and Depletion at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.1 million in Q3 2025.